Skip to content
MarketScale
‹ Back to IndustriesSciences

MarketScale Original Series: Welcome to the Show

Nothing says summer in America like our National Pastime. Terence Mann (played by James Earl Jones) may have said it best in the classic baseball movie Field of Dreams: “The one constant through all the years, Ray, has been baseball. America has rolled by like an army of steamrollers. It’s been erased like a blackboard, rebuilt,…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Featured Videos
Share
MarketScale Original Series: Welcome to the Show

Key takeaways

01

Nothing says summer in America like our National Pastime.

02

Terence Mann (played by James Earl Jones) may have said it best in the classic baseball movie Field of Dreams: “The one constant through all the years, Ray, has been baseball.

03

America has rolled by like an army of steamrollers.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Request an invite

Nothing says summer in America like our National Pastime.

Terence Mann (played by James Earl Jones) may have said it best in the classic baseball movie Field of Dreams:

“The one constant through all the years, Ray, has been baseball. America has rolled by like an army of steamrollers. It’s been erased like a blackboard, rebuilt, and erased again. But baseball has marked the time. This field, this game, is a part of our past, Ray. It reminds us of all that once was good, and that could be again.” 

And while baseball is a part of our past, the game faces challenges. In an accelerating world, a slowing pace of game is losing the attention of younger and older fans alike. If baseball is to retain its crown as the national pastime, it’s going to need new energy and increased engagement with its fans.

Enter the Savannah Bananas.

Owner Jesse Cole is making people fall in love with the game of baseball again one inning at a time with promotions not found anywhere else in the sport, delivering one sell-out after another. Summer nights at the Bananas’ Grayson Stadium are nothing short of magical, with the perfect fusion of good college baseball, and unmatched ‘fans first’ experiences.

But not without the challenges of running the organization, staying creative and for Jesse, delegating responsibility to his new Director of Fun, Tyler Gray.

MarketScale’s original series “Welcome to the Show” goes behind the scenes with the Bananas as they prepare for the 2018 home opener.

Three days before another summer of amateur baseball, the Savannah Bananas roster is just arriving at Grayson Stadium for the first time. Unlike most summer ball teams, the Bananas have different priorities than just shagging fly ball, taking batting practice and impressing scouts on day one. In this organization, it’s all about the show.

In just over 24 hours, the team will welcome 4,000 fans through the turnstiles just to watch practice, or “Fan Fest” as it’s called. First impressions are everything for the Bananas, and Fan Fest is the first impression of the summer for a team that cannot afford to play in front of sparse crowds.

In Tyler Gray’s debut, the team expects its entertainment to be bigger and bolder than ever before. But with a newcomer leading the way, this is easier said than done. Gray is taking the master of ceremonies reigns from Cole who, with a young family, is choosing to step back and delegate minute-by-minute operations to his staff.

Director of First Impressions Keke Coles begins a new season with dozens of new interns and volunteers as well. Few have ever experienced the pressure of putting on an entertaining experience that includes an all-you-can-eat buffet, zany promotions and plenty of chances to interact with the team.

Leading the players is new manager Tyler Gillum, who must not only coach the team to another winning season, but must also adapt to an environment where his roster is required to participate in off-field entertainment during games.

Tune in to Episode One of “Welcome to the Show”, to find out of the new staff can deliver the fan experience Savannah has come to expect with the Bananas, launch the first event of the season, and continue to reinvent the game of baseball.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Robotic Systems Emerge for Cell and Gene Therapy Manufacturing

Robotic Systems Emerge for Cell and Gene Therapy Manufacturing

A September 2024 Cytotherapy paper describes a robotic cluster designed to automate manual steps in cell therapy manufacturing. Additional reviews published in 2019 and 2026, along with commentary from Genetic Engineering and Biotechnology News, discuss automation and AI as tools being explored for the cell and gene therapy manufacturing sector.

  • 01A robotic cluster combining a robotic arm with customized modules can handle standard cell therapy equipment (incubators, bioreactors, reagent bags) without requiring entirely new manufacturing platforms.
  • 02The system produced human CD8+ T cells with cell yields, viability and identity comparable to manual cultures while maintaining sterility, according to the Cytotherapy paper.
  • 03Manufacturing automation and AI are cited in industry analysis as potential solutions to skilled labor shortages and production scaling challenges, particularly for allogeneic therapies manufactured at larger scale.

Sep 13, 2026

Deloitte's Biopharma AI Value Estimates Come With a Timing Catch

Deloitte's Biopharma AI Value Estimates Come With a Timing Catch

Deloitte's 2024 report, covered by TechTarget in April 2024, estimated that a top-10 biopharma company could capture $5-7 billion in peak AI value over five years, with about 90% concentrated in R&D, manufacturing/supply chain, and commercial functions. McKinsey reported in November 2025 that despite rising AI investment, pharma companies have not yet seen shorter development timelines or better clinical success rates.

  • 01Deloitte estimates $5–7B peak AI value for top-10 biopharma firms over five years, with cost reductions appearing in 1–2 quarters and revenue gains taking 3–4 quarters.
  • 02McKinsey found pharma companies have not yet achieved shorter drug development timelines or improved preclinical and clinical success rates despite increased AI spending.
  • 03AI systems used in manufacturing, supply chain, and R&D functions may require validation under existing regulated systems frameworks like GAMP.

Sep 13, 2026

CPC Biotech, Multiply Labs Develop Robot-Ready Cell Therapy Connector

CPC Biotech, Multiply Labs Develop Robot-Ready Cell Therapy Connector

CPC Biotech, part of PSG and Dover, announced on May 27, 2026 that it is collaborating with Multiply Labs to develop an aseptic connector designed for robotic operation. The companies said the connector combines CPC's MicroCNX Nano Series with a proprietary interface engineered for robotic grippers, giving robots a consistent contact point during aseptic fluid transfers in Multiply Labs' closed cell and gene therapy processing systems.

  • 01Robotic grippers can reliably handle rigid parts but struggle with soft materials like bags and tubing, driving demand for robot-compatible connectors in sterile processing.
  • 02Commercial cell therapy production was under 5,000 doses per year in 2023 while global demand was estimated in the millions, creating manufacturing constraints.
  • 03Cell therapy manufacturing may involve upwards of 40 process steps, and optimal workflows remain under development without industrywide standardization.

Sep 10, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512